Ely EW - Search Results

1

Recovery rate and prognosis in older persons who develop acute lung injury and the acute respiratory distress syndrome.

Ely EW, Wheeler AP, Thompson BT, Ancukiewicz M, Steinberg KP, Bernard GR. Ely EW, et al. Ann Intern Med. 2002 Jan 1;136(1):25-36. Ann Intern Med. 2002. PMID: 11777361 Clinical Trial.

2

Transfusions in critically ill patients.

Ely EW, Bernard GR. Ely EW, et al. N Engl J Med. 1999 Feb 11;340(6):467-8. doi: 10.1056/NEJM199902113400610. N Engl J Med. 1999. PMID: 9971873 No abstract available.

3

Efficacy and safety of recombinant human activated protein C for severe sepsis.

Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Bernard GR, et al. Among authors: ely ew. N Engl J Med. 2001 Mar 8;344(10):699-709. doi: 10.1056/NEJM200103083441001. N Engl J Med. 2001. PMID: 11236773 Free article. Clinical Trial.

4

Activated protein C for severe sepsis.

Ely EW, Bernard GR, Vincent JL. Ely EW, et al. N Engl J Med. 2002 Sep 26;347(13):1035-6. doi: 10.1056/NEJM200209263471315. N Engl J Med. 2002. PMID: 12324564 No abstract available.

5

Findings on the portable chest radiograph correlate with fluid balance in critically ill patients.

Martin GS, Ely EW, Carroll FE, Bernard GR. Martin GS, et al. Among authors: ely ew. Chest. 2002 Dec;122(6):2087-95. doi: 10.1378/chest.122.6.2087. Chest. 2002. PMID: 12475852 Clinical Trial.

6

Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis.

Angus DC, Linde-Zwirble WT, Clermont G, Ball DE, Basson BR, Ely EW, Laterre PF, Vincent JL, Bernard G, van Hout B; PROWESS Investigators. Angus DC, et al. Among authors: ely ew. Crit Care Med. 2003 Jan;31(1):1-11. doi: 10.1097/00003246-200301000-00001. Crit Care Med. 2003. PMID: 12544986 Clinical Trial.

7

Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis.

Ely EW, Laterre PF, Angus DC, Helterbrand JD, Levy H, Dhainaut JF, Vincent JL, Macias WL, Bernard GR; PROWESS Investigators. Ely EW, et al. Crit Care Med. 2003 Jan;31(1):12-9. doi: 10.1097/00003246-200301000-00002. Crit Care Med. 2003. PMID: 12544987 Clinical Trial.

8

Six-month neuropsychological outcome of medical intensive care unit patients.

Jackson JC, Hart RP, Gordon SM, Shintani A, Truman B, May L, Ely EW. Jackson JC, et al. Among authors: ely ew. Crit Care Med. 2003 Apr;31(4):1226-34. doi: 10.1097/01.CCM.0000059996.30263.94. Crit Care Med. 2003. PMID: 12682497

9

Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS).

Ely EW, Truman B, Shintani A, Thomason JW, Wheeler AP, Gordon S, Francis J, Speroff T, Gautam S, Margolin R, Sessler CN, Dittus RS, Bernard GR. Ely EW, et al. JAMA. 2003 Jun 11;289(22):2983-91. doi: 10.1001/jama.289.22.2983. JAMA. 2003. PMID: 12799407

10

Drotrecogin alfa (activated) treatment of older patients with severe sepsis.

Ely EW, Angus DC, Williams MD, Bates B, Qualy R, Bernard GR. Ely EW, et al. Clin Infect Dis. 2003 Jul 15;37(2):187-95. doi: 10.1086/375775. Epub 2003 Jul 8. Clin Infect Dis. 2003. PMID: 12856210 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

617 results

Search Page

Filters